Results 61 to 70 of about 42,347 (274)
Malignancy-Induced Hypercalcemia—Diagnostic Challenges
, 2017 Hypercalcemia in children is a rare metabolic finding. The clinical picture is usually non-specific, and the etiology includes several entities (metabolic, nutritional, drug-induced, inflammatory, cancer-associated, or genetic) depending on the age at ...
Claire Hoyoux +2 more
core +1 more source
Biochemical bone biomarkers in plasma cell dyscrasias
British Journal of Haematology, EarlyView.Visual abstract depicting that bone turnover markers reflect dynamic alterations in bone remodelling across the spectrum of plasma cell dyscrasias but remain limited by assay variability, biological confounding and incomplete integration with imaging and risk stratification.
Guido Nador +4 more
wiley +1 more source
British Journal of Haematology, EarlyView.Summary Although adult T‐cell leukaemia/lymphoma (ATL) has a higher burden in certain world regions, outcomes have not been directly compared across regions. We conducted a multicentre cohort study comparing the distribution of ATL subtypes and overall survival (OS) across 1090 adults (≥18 years) diagnosed with ATL during 2000–2023 in Japan (n = 366 ...
Bryan Valcarcel +31 more
wiley +1 more source
A Cross-Sectional Study to Determine the Prevalence of Calcium Metabolic Disorder in Malignant Childhood Cancers in Patients Admitted to the Pediatric Ward of Vali-Asr Hospital [PDF]
Acta Medica Iranica, 2011 Calcium metabolic disorders, such as hypercalcemia is a potentially life-threatening disorder especially when coupled with an already compromised condition. The aim of this study was to determine the prevalence of metabolic calcium disorders in childhood
Saudatu A. Sambo +2 more
doaj +2 more sources
International Journal of Emergency MedicineBackground Severe hypercalcemia often results in the referral of patients to the emergency department (ED), as life-threatening consequences are feared.
Franziska M. Himmels +6 more
doaj +1 more source
Cancer pain: current practice and emerging targets
British Journal of Pharmacology, EarlyView.Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
An unusual case of malignancy-related hypercalcemia
, 2013 Mary-Anne Doyle, Janine C Malcolm Division of Endocrinology, University of Ottawa, Ottawa, ON, Canada Objective: To report the case of a 28-year-old woman who presented with hypercalcemia (total calcium =4.11 mmol/L), elevated parathyroid hormone (PTH ...
Doyle MA, Malcolm JC
core
Clinical Endocrinology, EarlyView.ABSTRACT Context Placental calcium (Ca2+) transport is essential for foetal bone mineralisation and development, as well as for Ca2+ homoeostasis. Rare mutations in transient receptor potential vanilloid (TRPV) 6 of the infant cause insufficient maternal‐foetal Ca2+ transport through the placenta.
Teodora Grigore +6 more
wiley +1 more source
Vitamin D Supplementation to Prevent Post‐Thyroidectomy Hypocalcemia
Clinical Endocrinology, EarlyView.ABSTRACT Objective Hypocalcemia is the most common complication following thyroidectomy. Previous studies yielded inconsistent results on whether vitamin D3 prevents postoperative hypocalcemia and were conducted in non‐European countries with different dietary habits and baseline vitamin D levels.
Jeresa I. A. Willems +9 more
wiley +1 more source
[Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options]
, 2007 Hypercalcemia is a highly prevalent complication of sarcoidosis. A medical history of a patient with sarcoidosis is shown as case report. Depending on the population studied about 2-63% of sarcoidosis patients show hypercalcemia.
Ackermann, D
core